Palisade Bio, Inc. (PALI) — Financial statements
Income statement, balance sheet, and cash flow for Palisade Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00↓100.0% | 0.25 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.00 | 0.00↓100.0% | 0.25 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 10↑12.5% | 9↑31.5% | 7↑5.3% | 7↑169.4% | 2 | |
| General & Administrative Expenses | 8↑35.7% | 6↓6.5% | 6↓29.2% | 9↓5.8% | 9 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8↑35.7% | 6↓6.5% | 6↓29.2% | 9↓5.8% | 9 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 0.23↓45.1% | 0.41↓98.6% | 30 | |
| Operating Expenses | 18↑21.5% | 15↑11.6% | 13↓15.3% | 16↓62.4% | 42 | |
| Total Costs & Expenses | 18↑21.5% | 15↑11.6% | 13↓15.3% | 16↓62.4% | 42 | |
| Operating Results | ||||||
| Operating Income | -18↓21.5% | -15↓13.7% | -13↑16.9% | -16↑62.4% | -42 | |
| Depreciation & Amortization | 0.00↑0.0% | 0.00↓25.0% | 0.00↑33.3% | 0.00↑50.0% | 0.00 | |
| EBITDA | -17↓16.3% | -14↓17.4% | -12↑13.8% | -14↑41.2% | -24 | |
| EBIT | -17↓16.3% | -14↓17.4% | -12↑13.8% | -14↑41.2% | -24 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.01↑16.7% | -0.01↑20.0% | -0.02 | 0.00↑100.0% | -2 | |
| Interest Income | 0.00 | 0.00 | 0.00↓100.0% | 0.01 | 0.00 | |
| Interest Expense | 0.01↓16.7% | 0.01↓20.0% | 0.02↑15.4% | 0.01↓99.5% | 2 | |
| Non-Operating Income | -1↓196.8% | -0.43↑44.8% | -0.79↑46.7% | -1↑91.6% | -18 | |
| Other Income / Expenses | 1↑202.9% | 0.42↓45.3% | 0.77↓47.3% | 1↓90.4% | 15 | |
| Income Before Tax | -17↓16.2% | -14↓17.4% | -12↑13.7% | -14↑46.4% | -27 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -17↓16.2% | -14↓17.4% | -12↑13.7% | -14↑46.4% | -27 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -17↓16.2% | -14↓17.4% | -12↑13.7% | -14↑46.4% | -27 | |
| Bottom-Line Net Income | -17↓16.2% | -14↓17.2% | -12↑15.3% | -15↑54.2% | -32 | |
| EPS (Basic) | -0.30↑97.1% | -10.19↑62.3% | -27.01↓63.4% | -16.53↑99.2% | -2,144.25 | |
| EPS (Diluted) | -0.30↑97.1% | -10.19↑62.3% | -27.01↓63.4% | -16.53↑99.4% | -2,546.10 | |
| Weighted Average Shares | 56↑3831.5% | 1↑210.5% | 0.46↓48.2% | 0.88↑6990.1% | 0.01 | |
| Weighted Average Diluted Shares | 56↑3831.5% | 1↑210.5% | 0.46↓48.2% | 0.88↑6963.3% | 0.01 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.